| 1 |
30342195 | Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11/3A4 dysfunction through the pregnane X receptor. | 2019 Jan 30 |
2 |
| 2 |
31358899 | Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions. | 2019 Oct |
1 |
| 3 |
24486455 | Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro. | 2014 May |
1 |
| 4 |
21178302 | Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides. | 2011 |
4 |
| 5 |
20580705 | Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways. | 2010 Aug 25 |
4 |
| 6 |
20639434 | Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship. | 2010 Oct |
2 |
| 7 |
18628990 | Structure-activity relationship and substrate-dependent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes. | 2008 Jul 16 |
2 |
| 8 |
15133536 | The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. | 2004 May-Jun |
2 |
| 9 |
10574228 | Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. | 1999 |
1 |